SYBX Synlogic, Inc.
Healthcare$0.60+0.67%ClosedMarket Cap: $7.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.65
P/S
0.00
EV/EBITDA
1.62
DCF Value
$1.18
FCF Yield
-43.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-5.4%
ROA
-4.4%
ROIC
-36.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-1.3M | $681.0K | $— | — |
| Q4 null | $0.00 | NaN% | $-1.5M | $1.5M | $— | — |
| FY null | $0.00 | NaN% | $-4.0M | $-1.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-991.0K | $-2.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-777.0K | $-529.0K | $— | — |
| Q1 null | $0.00 | NaN% | $-898.0K | $317.0K | $— | — |
| Q4 null | $0.00 | NaN% | $-1.8M | $-714.0K | $— | — |
| FY null | $8.0K | 100.0% | $-41.0M | $-23.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-748.0K | $-117.0K | $— | — |
| Q2 null | $0.00 | NaN% | $-3.4M | $3.1M | $— | — |
| Q1 null | $8.0K | -16087.5% | $-10.6M | $-31.6M | $— | — |
| Q4 2023 | $2.8M | 54.1% | $-10.6M | $-14.5M | $-1.71 | — |